Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
The Oncologist
|
January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)
Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
Journal of Thoracic Disease
|
December 5, 2017
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors
Nicola Fazio, Antonio Ungaro, Francesca Spada, et al.
Endocrine
|
July 7, 2021
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience
Camilla Bardasi, Andrea Spallanzani, Stefania Benatti, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOC
Emilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
American Journal of Clinical Dermatology
|
October 8, 2024
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Laurent Mortier, Lisa Villabona, Ben Lawrence, et al.
Cancers
|
October 14, 2022
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
Nicola Fazio, Patrick Maisonneuve, Francesca Spada, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy
Riccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 25, 2021
Corrigendum to 'Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study' [European Journal of Cancer 154 (2021) 246-252]
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
European Journal of Endocrinology
|
November 30, 2023
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival
Anna La Salvia, Alberto Lens-Pardo, Angel López-López, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
The Oncologist
|
January 22, 2026
Everolimus as maintenance therapy in advanced neuroendocrine neoplasms: Results from the MAVERIC Phase II Trial (1499 WORDS MAIN TEXT)
Lorenzo Antonuzzo, Daniele Lavacchi, Francesca Spada, et al.
Journal of Thoracic Disease
|
December 5, 2017
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors
Nicola Fazio, Antonio Ungaro, Francesca Spada, et al.
Endocrine
|
July 7, 2021
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience
Camilla Bardasi, Andrea Spallanzani, Stefania Benatti, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
February 19, 2021
First <i>Ex Vivo</i> Results of β<sup>-</sup>-Radioguided Surgery in Small Intestine Neuroendocrine Tumors with <sup>90</sup>Y-DOTATOC
Emilio Bertani, Francesco Collamati, Marzia Colandrea, et al.
American Journal of Clinical Dermatology
|
October 8, 2024
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
Laurent Mortier, Lisa Villabona, Ben Lawrence, et al.
Cancers
|
October 14, 2022
Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
Nicola Fazio, Patrick Maisonneuve, Francesca Spada, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
October 7, 2025
AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy
Riccardo Laudicella, Antongiulio Faggiano, Valeria Pirro, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 25, 2021
Corrigendum to 'Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study' [European Journal of Cancer 154 (2021) 246-252]
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 23, 2021
Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
Nicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
European Journal of Endocrinology
|
November 30, 2023
Metabolomic profile of neuroendocrine tumors identifies methionine, porphyrin, and tryptophan metabolisms as key dysregulated pathways associated with patient survival
Anna La Salvia, Alberto Lens-Pardo, Angel López-López, et al.
Page
of 12